The use of high-sensitivity assays for C-reactive protein in clinical practice [0.03%]
高敏C反应蛋白检测在临床实践中的应用
Kiran Musunuru,Brian G Kral,Roger S Blumenthal et al.
Kiran Musunuru et al.
High-sensitivity assays that accurately measure levels of the inflammatory biomarker C-reactive protein have been proposed for use in assessments of risk for cardiovascular disease (CVD). A growing body of evidence supports recommendations ...
Eliminating out-of-pocket drug costs may improve outcomes after myocardial infarction--but at what cost to Medicare? [0.03%]
取消自付药物费用可能改善心脏病发作后的预后——但这将使 medicare 损失多少成本？
Andrew Moran,Lee Goldman
Andrew Moran
A standard four-drug regimen of aspirin, a beta-blocker, a lipid-lowering agent, and an angiotensin-converting-enzyme inhibitor or angiotensin-receptor blocker improves outcomes in survivors of myocardial infarction (MI), but adherence to t...
Ad J J C Bogers,A Pieter Kappetein
Ad J J C Bogers
Increased life expectancy has resulted in a growing population of elderly people, among whom aortic stenosis is increasingly prevalent. For the majority of patients, the treatment of aortic stenosis is surgical, and every symptomatic patien...
Referral to outpatient cardiac rehabilitation: intervention research at the patient, provider, and health system levels [0.03%]
患者、医疗提供者和卫生系统层面的介入研究：推荐进行门诊心脏康复治疗
Lisa Benz Scott
Lisa Benz Scott
This article sets out the clinical context of the research presented by Grace et al. in an accompanying article in this journal. Secondary preventive measures against cardiovascular disease, such as outpatient cardiac rehabilitation (OCR), ...
Werner Mohl,Stefan Mina,Dejan Milasinovic et al.
Werner Mohl et al.
Patricia A Pellikka,Thoralf M Sundt
Patricia A Pellikka
Bioabsorbable drug-eluting stents: the future of coronary angioplasty? [0.03%]
可降解药物洗脱支架：未来冠状动脉成形术的选择吗？
Carlos Macaya,Raul Moreno
Carlos Macaya
In the ABSORB trial, the feasibility of using a fully bioabsorbable everolimus-eluting stent (BVS; Abbott Vascular, Santa Clara, CA) in patients with ischemia and a single de novo coronary lesion was investigated. Some important concerns ab...
From randomized trials to registry studies: translating data into clinical information [0.03%]
从随机试验到注册研究：将数据转化为临床信息
Morgan L Brown,Bernard J Gersh,David R Holmes et al.
Morgan L Brown et al.
All clinicians face the challenge of practicing evidence-based medicine and are confronted with data from a variety of studies, ranging from prospective randomized and registry studies to retrospective analyses. Unfortunately, the data freq...
Which patients with venous thromboembolism are at risk for fatal pulmonary embolism? [0.03%]
哪些静脉血栓栓塞患者会发生致死性肺栓塞？
Alexander Gallus
Alexander Gallus
In a registry of 15,520 patients treated for symptomatic deep vein thrombosis or pulmonary embolism (PE), the 90-day mortality was 8.65% and death was attributed to PE in 1.68% of patients (19.4% of all deaths). Multivariate analysis define...